Evidence map›Paper›PMID 28346444›Full record

ArticleNature genetics2017

Genetic variants associated with mosaic Y chromosome loss highlight cell cycle genes and overlap with cancer susceptibility.

Daniel J Wright, Felix R Day, Nicola D Kerrison, Florian Zink, Alexia Cardona, Patrick Sulem, Deborah J Thompson, Svanhvit Sigurjonsdottir, Daniel F Gudbjartsson, Agnar Helgason and 9 more

Open access · greenAbstract read
In one paragraph

Article in Nature genetics, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 115 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
115citing papers in PubMed, 1 pooled it
9.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

115 citing papers in PubMed, 1 synthesis or guideline pooled it, 215 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Review
  6. Mosaic loss of Y chromosome associates with lung function, emphysema, and epigenetic aging.American journal of respiratory and critical care medicine · 2026
    Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Review
  19. Review
  20. Review

55 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 3 institutions in 2 countries.

Daniel J WrightMRC Epidemiology Unit, School of Clinical Medicine, University of Cambridge, Cambridge, UK.ORCID http://orcid.org/0000-0003-3983-2093
Felix R DayMRC Epidemiology Unit, School of Clinical Medicine, University of Cambridge, Cambridge, UK.ORCID http://orcid.org/0000-0003-3789-7651
Nicola D KerrisonMRC Epidemiology Unit, School of Clinical Medicine, University of Cambridge, Cambridge, UK.
Florian ZinkdeCODE Genetics-Amgen, Inc., Reykjavik, Iceland.
Alexia CardonaMRC Epidemiology Unit, School of Clinical Medicine, University of Cambridge, Cambridge, UK.
Patrick SulemdeCODE Genetics-Amgen, Inc., Reykjavik, Iceland.
Deborah J ThompsonCenter for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.ORCID http://orcid.org/0000-0003-1465-5799
Svanhvit SigurjonsdottirdeCODE Genetics-Amgen, Inc., Reykjavik, Iceland.
Daniel F GudbjartssondeCODE Genetics-Amgen, Inc., Reykjavik, Iceland.
Agnar HelgasondeCODE Genetics-Amgen, Inc., Reykjavik, Iceland.
J Ross ChapmanWellcome Trust Center for Human Genetics, University of Oxford, Oxford, UK.ORCID http://orcid.org/0000-0002-6477-4254
Steve P JacksonWellcome Trust and Cancer Research UK Gurdon Institute, University of Cambridge, Cambridge, UK.
Claudia LangenbergMRC Epidemiology Unit, School of Clinical Medicine, University of Cambridge, Cambridge, UK.
Nicholas J WarehamMRC Epidemiology Unit, School of Clinical Medicine, University of Cambridge, Cambridge, UK.
Robert A ScottMRC Epidemiology Unit, School of Clinical Medicine, University of Cambridge, Cambridge, UK.
Unnur ThorsteindottirdeCODE Genetics-Amgen, Inc., Reykjavik, Iceland.
Ken K OngMRC Epidemiology Unit, School of Clinical Medicine, University of Cambridge, Cambridge, UK.
Kari StefanssondeCODE Genetics-Amgen, Inc., Reykjavik, Iceland.
John R B PerryMRC Epidemiology Unit, School of Clinical Medicine, University of Cambridge, Cambridge, UK.
University of Cambridge · GBdeCODE Genetics (Iceland) · ISCentre for Human Genetics · GB

Funding

Cancer Research UK 18796Cancer Research UK 19270Medical Research Council MC_EX_MR/L100002/1Medical Research Council MC_QA137853Medical Research Council MC_UU_12015/1Medical Research Council MC_UU_12015/2Medical Research Council MR/M009971/1Wellcome Trust
6 · The paper itself

Abstract

The Y chromosome is frequently lost in hematopoietic cells, which represents the most common somatic alteration in men. However, the mechanisms that regulate mosaic loss of chromosome Y (mLOY), and its clinical relevance, are unknown. We used genotype-array-intensity data and sequence reads from 85,542 men to identify 19 genomic regions (P < 5 × 10

Indexed as

Genetic VariationCell CycleChromosome DeletionChromosomes, Human, XChromosomes, Human, YDNA MethylationFemaleGenetic Predisposition to DiseaseGenome, HumanGenome-Wide Association StudyGenomic InstabilityGenotypeHumansINDEL MutationMaleNeoplasms

Identifiers

PMID28346444
PMCPMC5973269
OpenAlexW2599652322

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.